CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 67.52 CNY -4.43% Market Closed
Market Cap: 7.7B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Relative Value

The Relative Value of one CanSino Biologics Inc stock under the Base Case scenario is 80.08 CNY. Compared to the current market price of 67.52 CNY, CanSino Biologics Inc is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
80.08 CNY
Undervaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
64
vs Industry
14
Median 3Y
12.2
Median 5Y
14.8
Industry
2.6
Forward
9.1
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-5.4
Industry
23
Forward
-41.6
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-8
Industry
17.8
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-5.8
Industry
25.4
vs History
77
vs Industry
64
Median 3Y
1.8
Median 5Y
2.3
Industry
2.2
vs History
67
vs Industry
21
Median 3Y
8.4
Median 5Y
10.9
Industry
2.8
Forward
6.9
vs History
49
vs Industry
10
Median 3Y
12.1
Median 5Y
14
Industry
5.4
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-3.2
Industry
13.7
Forward
2 396
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-3.2
Industry
17.2
Forward
-13.8
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-5.9
Industry
16.5
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-4.3
Industry
19.3
vs History
77
vs Industry
73
Median 3Y
1.6
Median 5Y
2.5
Industry
2

Multiples Across Competitors

Competitors Multiples
CanSino Biologics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
CanSino Biologics Inc
SSE:688185
7.7B CNY 12.2 -8.9 -6.7 -6.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
CN
CanSino Biologics Inc
SSE:688185
Average P/E: 33.4
Negative Multiple: -8.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top